A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Conditions
- Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
- Advanced Head and Neck Squamous Cell Carcinoma
- Advanced Esophageal Squamous Cell Carcinoma
- Cervical Squamous Cell Carcinoma
- Advanced Cutaneous Squamous Cell Carcinoma
- Nasopharyngeal Cancinoma (NPC)
- Squamous Cell Carcinoma
Interventions
- DRUG: HMBD-001
- DRUG: Docetaxel
- DRUG: Cetuximab
Sponsor
Hummingbird Bioscience
Collaborators